CML - Evidence Based Medicine

Comprehensive Clinical Update on Chronic Myeloid Leukemia (CML): Pathophysiology, Diagnosis, Risk Stratification, and Evidence-Based Management

Post author:doctorcostamed
Post published:June 20, 2022
Post category:Medicine
Post comments:0 Comments

Prepared for the practicing hematologist/oncologist — incorporating 2023–2024 guidelines (NCCN, ELN, ESMO) and key recent trials (Eneomab, IRIS-15, OPTIC, ASCEND, FREE-SCIPHY) I. Disease Overview & Molecular Pathogenesis Chronic myeloid leukemia…

Dasatinib – Indications, and Side Effects

Post author:doctorcostamed
Post published:February 21, 2022
Post category:Medicine
Post comments:0 Comments

1. Introduction Dasatinib (brand name Sprycel) is a second-generation, reversible tyrosine kinase inhibitor (TKI) primarily used in the management of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Philadelphia chromosome-positive…